ClinicalTrials.gg
RecruitingNCT06321042SYMPHO-EMUpdated Apr 23, 2026

Evaluation of the Clinical Outcomes of the Total Knee ps Prosthesis Implanted With the Use of Inertial Sensors

An observational study in Prosthesis Durability, sponsored by Istituto Ortopedico Rizzoli. Recruiting at 1 site in Italy. Open to participants aged 50 Years to 85 Years. Per ClinicalTrials.gov, last updated 2026-04-23.

Sponsored by Istituto Ortopedico Rizzoli · Observational

From the registry’s dates

  • Started Jan 2023; still recruiting 3 years 9 months later.
Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
40
Ages
50 Years to 85 Years
Sex
All
01

Study summary

evaluate the clinical outcome of the implantation of a specific primary TKA model implanted with the aid of inertial sensors for the execution of bone cuts through the administration of questionnaires for the calculation of clinical-functional scores;

02

Conditions studied

  • Prosthesis Durability

Browse trials for

03

In context

Prosthesis Failure

119 studies on the registry are indexed under Prosthesis Failure; 35 are open to participants now.

This study's planned enrollment of 40 is below the median of 119 across 49 observational studies indexed under Prosthesis Failure.

Browse Prosthesis Failure studies →

Lead sponsor

Istituto Ortopedico Rizzoli is the lead sponsor of 304 studies on the registry; 103 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
50 Years to 85 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Patients candidates to TKA surgery

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. Male and female subjects 50 years of age or older and less than 85 years of age (>50 and \<85 years) who are candidates for primary cemented total knee replacement based on physical examination and medical history, including diagnosis of severe knee pain and disability due to at least one of the following causes:

    • to. Primary or secondary osteoarthritis
    • b. Collagen disorders and/or avascular necrosis of femoral condyle
    • c. Moderate valgus, varus or flexion deformities (HKA between ± 10°, flexion contracture \<10°) -
  2. Patients consent and able to complete scheduled study procedures and follow-up assessments.
  3. Patients informed about the nature of the study who signed the "" approved by the ethics committee.

Exclusion criteria

Exclusion Criteria:

  • Simultaneous participation in other studies
  • Patients not capable of understanding and wanting and therefore unable to sign the
  • Patients who have already undergone hip or ankle arthroplasty, previous osteotomy, with severe axial deformities or suffering from rheumatoid arthritis, diabetes or neuromuscular diseases.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
40 participants (estimated)
Patient registry
No

Groups and cohorts

  • Patient treated with PS Link Symphoknee prosthesis and Orthokey perseus alignment device

    Device: Knee arthroplasty

Interventions

  • DeviceKnee arthroplasty

    Knee arthroplasty surgery with perseus orthokey alignment device

06

What researchers measure

Primary outcomes

  1. Knee Society Score

    Two sections, one evaluating the patient's function and one for his clinical conditions, overall score goes from 0 to 100

    Time frame: at baseline (day 0)

  2. Knee Society Score

    Two sections, one evaluating the patient's function and one for his clinical conditions, overall score goes from 0 to 100

    Time frame: 6 months

  3. Knee Society Score

    Two sections, one evaluating the patient's function and one for his clinical conditions, overall score goes from 0 to 100

    Time frame: 12 months

  4. Knee Society Score

    Two sections, one evaluating the patient's function and one for his clinical conditions, overall score goes from 0 to 100

    Time frame: 24 months

  5. Western Ontario and McMaster Universities Arthritis Index

    The test evaluates main aspects of arthritis such as pain, stiffness articulation and functionality. The score goes from 0 to 96

    Time frame: at baseline (day 0)

  6. Western Ontario and McMaster Universities Arthritis Index

    The test evaluates main aspects of arthritis such as pain, stiffness articulation and functionality. The score goes from 0 to 96

    Time frame: 6 months

  7. Western Ontario and McMaster Universities Arthritis Index

    The test evaluates main aspects of arthritis such as pain, stiffness articulation and functionality. The score goes from 0 to 96

    Time frame: 12 months

  8. Western Ontario and McMaster Universities Arthritis Index

    The test evaluates main aspects of arthritis such as pain, stiffness articulation and functionality. The score goes from 0 to 96

    Time frame: 24 months

  9. Knee injury and Osteoarthritis Outcome Score

    The KOOS holds five separately scored subscales: Pain, other Symptoms, Function in daily living (ADL), Function in Sport and Recreation (Sport/Rec), and knee-related Quality of Life (QOL). the score goes from 0 to 100

    Time frame: at baseline (day 0)

  10. Knee injury and Osteoarthritis Outcome Score

    The KOOS holds five separately scored subscales: Pain, other Symptoms, Function in daily living (ADL), Function in Sport and Recreation (Sport/Rec), and knee-related Quality of Life (QOL). the score goes from 0 to 100

    Time frame: 6 months

  11. Knee injury and Osteoarthritis Outcome Score

    The KOOS holds five separately scored subscales: Pain, other Symptoms, Function in daily living (ADL), Function in Sport and Recreation (Sport/Rec), and knee-related Quality of Life (QOL). the score goes from 0 to 100

    Time frame: 12 months

  12. Knee injury and Osteoarthritis Outcome Score

    The KOOS holds five separately scored subscales: Pain, other Symptoms, Function in daily living (ADL), Function in Sport and Recreation (Sport/Rec), and knee-related Quality of Life (QOL). the score goes from 0 to 100

    Time frame: 24 months

  13. 36-Item Short Form Health Survey

    is a valid and reliable tool for measuring health outcomes in patients with musculoskeletal pain, but its sensitivity to clinical changes in patients with specific disorders may be limited, rated on a scale of 0 to 100, with 0 and 100 being minimum and maximum possible scores.

    Time frame: at baseline (day 0)

  14. 36-Item Short Form Health Survey

    is a valid and reliable tool for measuring health outcomes in patients with musculoskeletal pain, but its sensitivity to clinical changes in patients with specific disorders may be limited, rated on a scale of 0 to 100, with 0 and 100 being minimum and maximum possible scores.

    Time frame: 6 months

  15. 36-Item Short Form Health Survey

    is a valid and reliable tool for measuring health outcomes in patients with musculoskeletal pain, but its sensitivity to clinical changes in patients with specific disorders may be limited, rated on a scale of 0 to 100, with 0 and 100 being minimum and maximum possible scores.

    Time frame: 12 months

  16. 36-Item Short Form Health Survey

    is a valid and reliable tool for measuring health outcomes in patients with musculoskeletal pain, but its sensitivity to clinical changes in patients with specific disorders may be limited, rated on a scale of 0 to 100, with 0 and 100 being minimum and maximum possible scores.

    Time frame: 24 months

  17. Forgotten joint score

    a 12-question patient-reported outcomes measure created to measure a patient's awareness of their artificial joint

    Time frame: at baseline (day 0)

  18. Forgotten joint score

    a 12-question patient-reported outcomes measure created to measure a patient's awareness of their artificial joint

    Time frame: 6 months

  19. Forgotten joint score

    a 12-question patient-reported outcomes measure created to measure a patient's awareness of their artificial joint

    Time frame: 12 months

  20. Forgotten joint score

    a 12-question patient-reported outcomes measure created to measure a patient's awareness of their artificial joint

    Time frame: 24 months

Secondary outcomes

  1. Radiographic evaluation of prosthetic femoral component positioning

    measurement of prosthetic femoral component alignment according to femoral mechanical axis

    Time frame: 5 days after index surgery

07

Study locations

1 of 1 sites recruiting
08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Jan 2023 (actual). Primary completion is estimated for Jan 2027, 48 months after the start.

Of 28 observational studies under Prosthesis Failure, half reached primary completion within 181 months of starting (the median), counting those still running; a quarter within 57 and three quarters within 184. This study's planned 48 months is below that.

How these figures are worked out, and which studies are left out of them.

Registered
Jan 13, 2024
First posted
Mar 20, 2024
StartActual
Jan 13, 2023
Primary completionEst.
Jan 2027
CompletionEst.
Mar 2027
Last update
Apr 23, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Apr 23, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT06321042
Responsible party
Stefano Zaffagnini (Full Professor Medicine and Surgery, University of Bologna, Istituto Ortopedico Rizzoli) — Principal investigator
First posted
Mar 20, 2024
Start date
Jan 13, 2023
Primary completion
Jan 2027 (estimated)
Completion
Mar 2027 (estimated)
Last update
Apr 23, 2026

Study contacts

Stefano Zaffagnini, Prof
Contact
stefano.zaffagnini@unibo.it
0516366075

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion